| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Surgery and Research, University of Basel, Basel, Switzerland [T. K., E. S-T., C. S., A. J., T. W., F. H., M. H., G. C. S.]; Department of Pathology, University of Basel, Basel, Switzerland [F. G.]; and Dipartimento Biotecnologie H.S. Raffaele, Milan, Italy [G. C.]
The human MAGE-3 gene encodes a melanoma antigenic epitope recognized by specific cytotoxic T lymphocytes, but its gene product has not been identified thus far. We produced a recombinant MAGE-3 gene product by expression cloning of the entire reading frame in the context of a fusion protein characterized by a 10-histidine tail, allowing purification by metal chelation on a nickel Sepharose column. The semipurified product was used to generate MAGE-3-specific monoclonal antibodies. One reagent could identify by immunoblotting the native MAGE-3 gene product as a Mr 48,000 protein in lysates of cell lines showing evidence of MAGE-3 gene expression. No apparent cross-reactivity with recombinant or native MAGE-1 gene product was observed. Immunohistochemistry shows that, closely resembling the MAGE-1 gene product, MAGE-3 is a cytoplasmic protein.
1 This work was supported by grants from the Swiss Cancer League; the Regional Cancer Leagues of Basel-Stadt, Basel-Land, and St. Gallen-Appenzell; the S. Salvatore (Lugano) and Roche (Bern) Research Foundations; the Karl Mayer Foundation (Liechtenstein); and the Swiss National Fund (Grants 31-36295.92 to G. C. S. and 31-39509.93 to A. J.). G. C. was supported by Grants from Associazione Italiana per la Ricerca sul Cancro (7th project; Italy).
2 The first two authors contributed equally to this work.
3 To whom requests for reprints should be addressed, at Surgical Research Laboratory, 20 Hebelstrasse, 4031 Basel, Switzerland.
Received 2/21/95. Accepted 4/20/95.
This article has been cited by other articles:
|
|
 |
|
  D. Atanackovic, J. Arfsten, Y. Cao, S. Gnjatic, F. Schnieders, K. Bartels, G. Schilling, C. Faltz, C. Wolschke, J. Dierlamm, et al. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation Blood, February 1, 2007; 109(3): 1103 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sharma, Y. Shen, S. Wen, D. F. Bajorin, V. E. Reuter, L. J. Old, and A. A. Jungbluth Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma. Clin. Cancer Res., September 15, 2006; 12(18): 5442 - 5447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sato, S. H. Olson, J. Ahn, B. Bundy, H. Nishikawa, F. Qian, A. A. Jungbluth, D. Frosina, S. Gnjatic, C. Ambrosone, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer PNAS, December 20, 2005; 102(51): 18538 - 18543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Jungbluth, S. Ely, M. DiLiberto, R. Niesvizky, B. Williamson, D. Frosina, Y.-T. Chen, N. Bhardwaj, S. Chen-Kiang, L. J. Old, et al. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation Blood, July 1, 2005; 106(1): 167 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Schaft, J. Dorrie, P. Thumann, V. E. Beck, I. Muller, E. S. Schultz, E. Kampgen, D. Dieckmann, and G. Schuler Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation J. Immunol., March 1, 2005; 174(5): 3087 - 3097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Utsunomiya, H. Inoue, F. Tanaka, H. Yamaguchi, M. Ohta, M. Okamoto, K. Mimori, and M. Mori Expression of Cancer-Testis Antigen (CTA) Genes in Intrahepatic Cholangiocarcinoma Ann. Surg. Oncol., October 1, 2004; 11(10): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, L. Lin, D. G. Thomas, J. K. Greenson, T. J. Giordano, G. S. Robinson, R. A. Barve, F. A. Weishaar, J. M. G. Taylor, M. B. Orringer, et al. Melanoma-Associated Antigens in Esophageal Adenocarcinoma: Identification of Novel MAGE-A10 Splice Variants Clin. Cancer Res., September 1, 2004; 10(17): 5708 - 5716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Laduron, R. Deplus, S. Zhou, O. Kholmanskikh, D. Godelaine, C. De Smet, S. D. Hayward, F. Fuks, T. Boon, and E. De Plaen MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription Nucleic Acids Res., August 17, 2004; 32(14): 4340 - 4350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Breckpot, C. Heirman, C. De Greef, P. van der Bruggen, and K. Thielemans Identification of New Antigenic Peptide Presented by HLA-Cw7 and Encoded by Several MAGE Genes Using Dendritic Cells Transduced with Lentiviruses J. Immunol., February 15, 2004; 172(4): 2232 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Westbrook, P. D. Schoppee, A. B. Diekman, K. L. Klotz, M. Allietta, K. T. Hogan, C. L. Slingluff, J. W. Patterson, H. F. Frierson, W. P. Irvin Jr., et al. Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell Lines Clin. Cancer Res., January 1, 2004; 10(1): 101 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yakirevich, E. Sabo, O. Lavie, S. Mazareb, G. C. Spagnoli, and M. B. Resnick Expression of the MAGE-A4 and NY-ESO-1 Cancer-Testis Antigens in Serous Ovarian Neoplasms Clin. Cancer Res., December 15, 2003; 9(17): 6453 - 6460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Consogno, S. Manici, V. Facchinetti, A. Bachi, J. Hammer, B. M. Conti-Fine, C. Rugarli, C. Traversari, and M. P. Protti Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3 Blood, February 1, 2003; 101(3): 1038 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Morishima, K. Nakanishi, H. Takenouchi, T. Shibata, and Y. Yasuhiko An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis. CYTOCHROME c-INDEPENDENT ACTIVATION OF CASPASE-9 BY CASPASE-12 J. Biol. Chem., September 6, 2002; 277(37): 34287 - 34294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Taback, A. D. Chan, C. T. Kuo, P. J. Bostick, H.-J. Wang, A. E. Giuliano, and D. S. B. Hoon Detection of Occult Metastatic Breast Cancer Cells in Blood by a Multimolecular Marker Assay: Correlation with Clinical Stage of Disease Cancer Res., December 1, 2001; 61(24): 8845 - 8850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rimoldi, K. Muehlethaler, S. Salvi, D. Valmori, P. Romero, J.-C. Cerottini, and F. Levy Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted Epitope J. Biol. Chem., November 9, 2001; 276(46): 43189 - 43196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. You, J. Hester, L. Rollins, G. C. Spagnoli, P. van der Bruggen, and S.-Y. Chen A Retrogen Strategy for Presentation of an Intracellular Tumor Antigen as an Exogenous Antigen by Dendritic Cells Induces Potent Antitumor T Helper and CTL Responses Cancer Res., January 1, 2001; 61(1): 197 - 205. [Abstract] [Full Text]
|
|
|
|
|
|
C. Österlund, V. Töhönen, K. O. Forslund, and K. Nordqvist Mage-b4, a Novel Melanoma Antigen (MAGE) Gene Specifically Expressed during Germ Cell Differentiation Cancer Res., February 1, 2000; 60(4): 1054 - 1061. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. W. Zendman, I. M. H. A. Cornelissen, U. H. Weidle, D. J. Ruiter, and G. N. P. van Muijen CTp11, a Novel Member of the Family of Human Cancer/Testis Antigens Cancer Res., December 1, 1999; 59(24): 6223 - 6229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Baren, F. Brasseur, D. Godelaine, G. Hames, A. Ferrant, F. Lehmann, M. Andre, C. Ravoet, C. Doyen, G. C. Spagnoli, et al. Genes Encoding Tumor-Specific Antigens Are Expressed in Human Myeloma Cells Blood, August 15, 1999; 94(4): 1156 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Valmori, U. Gileadi, C. Servis, P. R. Dunbar, J.-C. Cerottini, P. Romero, V. Cerundolo, and F. Levy Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte-defined Peptide Derived from the Tumor Antigen MAGE-3 J. Exp. Med., March 15, 1999; 189(6): 895 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Manici, T. Sturniolo, M. A. Imro, J. Hammer, F. Sinigaglia, C. Noppen, G. Spagnoli, B. Mazzi, M. Bellone, P. Dellabona, et al. Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 J. Exp. Med., March 1, 1999; 189(5): 871 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Chen, S.-H. Lin, L. W. K. Chung, and R. A. Sikes Isolation and Characterization of PAGE-1 and GAGE-7. NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS J. Biol. Chem., July 10, 1998; 273(28): 17618 - 17625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Saburi, D. Nadano, T. O. Akama, K. Hirama, K. Yamanouchi, K. Naito, H. Tojo, C. Tachi, and M. N. Fukuda The Trophinin Gene Encodes a Novel Group of MAGE Proteins, Magphinins, and Regulates Cell Proliferation during Gametogenesis in the Mouse J. Biol. Chem., December 21, 2001; 276(52): 49378 - 49389. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
